Global Tissue Microarray Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Tissue Microarray Market was valued at $13.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.8% CAGR, to an estimated market size of $22.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Tissue Microarray (TMA) market comprises high-throughput technology platforms used for the simultaneous analysis of multiple tissue specimens on a single histological slide. This process involves extracting cylindrical tissue cores from donor paraffin blocks and re-embedding them into a recipient block, enabling large-scale protein, DNA, or RNA expression profiling under identical experimental conditions for applications in oncology research, drug discovery, and molecular diagnostics.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Tissue Microarray Market in the period 2025-30:
- The rising global cancer burden is the primary driver, necessitating high-throughput tools for large-scale tumor heterogeneity analysis and biomarker identification.
- A significant shift toward precision medicine and personalized oncology is increasing the demand for TMAs in companion diagnostic development and patient stratification.
- The integration of artificial intelligence (AI) and machine learning into digital pathology is enhancing the accuracy of data interpretation and automated scoring.
- Technological transitions from manual arraying to fully automated tissue arrayers are streamlining laboratory workflows and improving reproducibility.
- Increased R&D investment from pharmaceutical and biotechnological companies is accelerating the use of TMAs in drug discovery and lead discovery processes.
- The adoption of multiplex immunohistochemistry is allowing researchers to analyze multiple biomarkers within a single tissue section, maximizing data yield from limited samples.
- Market growth is partially restrained by the high initial setup costs and the technical complexity associated with data interpretation and tissue sourcing.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Immunohistochemistry (IHC)
- Fluorescence In Situ Hybridization (FISH)
- Other Procedures (PCR, NGS, Frozen)